ALEXANDRIA, Va., July 16 -- United States Patent no. 12,360,121, issued on July 15, was assigned to Syracuse University (Syracuse, N.Y.).

"Assay for detection of an A2E-Saposin B complex" was invented by Robert P. Doyle (Manlius, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "An assay and kit for detecting N-retinylidene-N-retinylethanolamine (A2E) in a sample that uses a lipid binding protein, such as Saposin B, to capture A2E in the sample and assist in the extraction and measurement of A2E via mass spectroscopy. A2E thus serves as a marker for macular degeneration so that the assay and kit of the invention can be used to detect the presence or severity of macular degeneration."

The patent was filed ...